Category Archives: Healthcare

Healthcare Press Releases & News distributed via EuropaWire

FDA Gives Nod to Fresenius Kabi’s Tyenne®: A Dual-Format Tocilizumab Biosimilar Advancement

(IN BRIEF) Fresenius Kabi announces FDA approval of Tyenne® (tocilizumab-aazg), the first tocilizumab biosimilar offering both IV and subcutaneous formulations. This marks a significant milestone in the company’s growth strategy (#FutureFresenius) and expands treatment options for inflammatory, autoimmune diseases, and … Read the full press release

GSK Reports Positive Results from DREAMM-8 Phase III Trial of Blenrep in Multiple Myeloma Treatment

(IN BRIEF) GSK has announced encouraging findings from the interim analysis of the DREAMM-8 phase III trial evaluating Blenrep (belantamab mafodotin) in combination with pomalidomide plus dexamethasone (PomDex) compared to the standard of care, bortezomib plus PomDex, for relapsed or … Read the full press release

Novo Nordisk Hosts Capital Markets Day to Share Progress on Strategic Aspirations 2025

(IN BRIEF) Novo Nordisk is conducting a Capital Markets Day (CMD) to provide updates on its Strategic Aspirations 2025. The event will focus on various aspects, including corporate strategy, sustainability, research and development pipeline, and financial performance. Highlights include discussions … Read the full press release

Philips Tops Clarivate’s 2024 Global Innovator List for 11th Consecutive Year

(IN BRIEF) Royal Philips, a prominent figure in health technology, has once again secured its position in the 2024 Clarivate Top 100 Global Innovator™ list, marking its eleventh consecutive inclusion. With a dedication to R&D programs and collaborative efforts, Philips … Read the full press release

Biotech Acceleration: Evotec and Claris Ventures Unite to Propel Portfolio Companies Forward

(IN BRIEF) Evotec and Claris Ventures have formed a strategic partnership to accelerate the progress of biotech ventures in Claris’s portfolio into clinical trials. This collaboration allows Claris’s portfolio companies, focused on biotech ventures nearing clinical trials, streamlined access to … Read the full press release

Novo Nordisk’s Semaglutide Shows Promise in Kidney Outcomes Trial FLOW

(IN BRIEF) Novo Nordisk has announced promising headline results from the kidney outcomes trial FLOW, which compared injectable semaglutide 1.0 mg with placebo as an adjunct to standard care for people with type 2 diabetes and chronic kidney disease (CKD). … Read the full press release

What’s new in cancer care across Europe in early 2024 (1 Jan – 5 Mar 2024): Advancements, Innovations, Research, Awareness

(IN BRIEF) In early 2024, Europe’s medical and research communities announced major breakthroughs in cancer care, highlighting new treatments like AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan for lung and breast cancer, and AstraZeneca’s Tagrisso for EGFR-mutated lung cancer. Diagnostic advancements … Read the full press release

Phagenesis Secures $42M Investment Led by EQT Life Sciences to Revolutionize Swallowing Disorder Treatment

(IN BRIEF) Phagenesis, a UK-based medical technology company specializing in treating swallowing disorders, has closed a significant $42 million Series D financing round led by EQT Life Sciences, with co-leadership from Sectoral Asset Management. This substantial investment reflects confidence in … Read the full press release

EMA Validates Marketing Authorisation Applications for AstraZeneca and Daiichi Sankyo’s Datopotamab Deruxtecan in Lung and Breast Cancer Treatment

(IN BRIEF) The European Medicines Agency (EMA) has validated two marketing authorisation applications (MAAs) for datopotamab deruxtecan (Dato-DXd), developed by AstraZeneca and Daiichi Sankyo, for the treatment of nonsquamous non-small cell lung cancer (NSCLC) and hormone receptor (HR)-positive, HER2-negative breast … Read the full press release

Empathetic Communication Found Effective in Addressing Vaccine Hesitancy, Study Shows

(IN BRIEF) A groundbreaking international study led by the University of Bristol reveals the effectiveness of empathetic correction of misinformation in improving attitudes towards vaccination, particularly among vaccine-hesitant individuals. The research, published in Health Psychology, highlights the significance of empathetic … Read the full press release

Genetic Study Reveals Potential for Tailored Breast Cancer Screening

(IN BRIEF) A recent genetic study conducted by researchers at the University of Helsinki suggests that genetic risk information could revolutionize breast cancer screening, potentially benefiting one in ten women. The study indicates that a comprehensive genetic risk profile could … Read the full press release

Prosus Ventures Backs Kismet with $8.2M Seed Investment for Healthcare Innovation

(IN BRIEF) Kismet, a healthcare startup, has secured $8.2 million in seed funding led by Prosus Ventures and Airtree Ventures, bringing its total financing to $10.8 million since its founding in February 2023. The funding will accelerate Kismet’s mission to … Read the full press release

Novartis Unveils Promising Results from SMART Study: Zolgensma’s Efficacy Confirmed in Older and Heavier SMA Patients

(IN BRIEF) Novartis has presented compelling data from the SMART study, reinforcing the clinical advantages of Zolgensma® (onasemnogene abeparvovec) in treating spinal muscular atrophy (SMA) patients weighing ≥ 8.5 kg to ≤ 21 kg, with a mean age of 4.69 … Read the full press release

The European companies at MWC Barcelona 2024: AI, 5G, VR, XR, Cybersecurity, Digital Transformation, Entertainment, etc.

(IN BRIEF) At the Mobile World Congress (MWC) Barcelona 2024, European companies showcased a wide array of innovations and strategic partnerships that underscored their commitment to driving digital transformation and enhancing connectivity across various sectors. The key topics discussed by … Read the full press release

Driving Innovation: Henkel Spotlights Self-Regulating PTC Heaters and More at LOPEC 2024

(IN BRIEF) Henkel, a leading provider of printed electronics materials, is set to showcase its latest innovations at the LOPEC trade show. They will unveil their functional materials tailored for smart surfaces, healthcare, and connectivity applications. The focus will be … Read the full press release

Eckert & Ziegler’s GalliaPharm® Generator Powers Groundbreaking Cancer Diagnostic Trial in Japan

(IN BRIEF) Eckert & Ziegler, in collaboration with Novartis Pharma K.K., is expanding Ga-68 labeled diagnostics in Japan through a clinical trial approved by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). Utilizing Eckert & Ziegler’s GalliaPharm® generator, the trial … Read the full press release

Leading Healthcare Giant Fresenius Establishes ESG Advisory Board

(IN BRIEF) Fresenius, a global healthcare group, has appointed an independent advisory board to focus on sustainability issues. Comprising four experts from various fields, the board will support the development of Fresenius’ sustainability strategy. This move reflects Fresenius’ commitment to … Read the full press release

trinamiX Unveils Groundbreaking Consumer Spectroscopy Solution at MWC Barcelona 2024

(IN BRIEF) trinamiX GmbH debuts its latest innovation, the Consumer Spectroscopy solution, at the Mobile World Congress in Barcelona. This cutting-edge technology integrates a near-infrared (NIR) spectrometer into a smartphone reference design powered by Qualcomm’s Snapdragon® 8 Gen 3 platform, … Read the full press release

Voydeya Recommended for EU Marketing Authorization as PNH Treatment Add-On

(IN BRIEF) Voydeya (danicopan), a first-in-class oral Factor D inhibitor, has been recommended for marketing authorization in the European Union (EU) as an add-on to ravulizumab or eculizumab for adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who experience residual haemolytic … Read the full press release

GSK’s Gepotidacin Shows Promise as Gonorrhoea Treatment: Positive Results from EAGLE-1 Trial

(IN BRIEF) GSK plc has announced positive headline results from the pivotal EAGLE-1 phase III trial for gepotidacin, an oral antibiotic aimed at treating uncomplicated urogenital gonorrhoea in adolescents and adults. The trial demonstrated gepotidacin’s non-inferiority compared to the current … Read the full press release

Boosting Grenada’s Healthcare: CDB and EIB Announce Major Funding Initiative

(IN BRIEF) Grenada’s healthcare infrastructure is set to undergo a significant transformation with a US$ 9,970,500 loan from the Caribbean Development Bank (CDB), financed by the European Investment Bank (EIB). The project, launched in St. George’s, Grenada, aims to strengthen … Read the full press release

Boehringer Ingelheim’s Survodutide Shows Promising Results as Potential Best-in-Class Treatment for MASH in Phase II Trial

(IN BRIEF) Boehringer Ingelheim has reported compelling results from its Phase II trial of Survodutide, a novel glucagon/GLP-1 receptor dual agonist, indicating its potential to become a leading treatment for Metabolic Dysfunction-Associated Steatohepatitis (MASH). In the trial, up to 83.0% … Read the full press release

ZEISS and University of Oxford Collaborate to Advance Biomedical Imaging

(IN BRIEF) The University of Oxford and ZEISS have inaugurated the Oxford-ZEISS Centre of Excellence in Biomedical Imaging, promising cutting-edge microscopy and imaging technologies to further research in global health and disease. This collaboration between the Kennedy Institute of Rheumatology, … Read the full press release

Comprehensive Review in The Lancet Explores Atrial Fibrillation Risk Factors and Management

(IN BRIEF) A recent comprehensive review published in The Lancet Regional Health Europe offers insights into the risk factors and management strategies for atrial fibrillation (AF), a prevalent heart rhythm disorder affecting millions globally. Conducted by researchers from the University … Read the full press release

ETZ Hospital Secures €115 Million Financing for Modernization and Sustainability Drive

(IN BRIEF) ETZ hospital has finalized a €115 million financing deal with the European Investment Bank (EIB) and BNG Bank to support the modernization of its St. Elisabeth location in Tilburg. This funding will facilitate the construction of a new … Read the full press release

The latest on quantum computing in Europe, January 2023 – February 2024

(IN BRIEF) Europe has made significant progress in quantum computing with investments, partnerships, and innovations. Highlights include a €3.5 million investment in LioniX International by the University of Twente, and T-Systems offering cloud access to IBM’s quantum systems. Other developments … Read the full press release

Novo Nordisk Announces Annual General Meeting Date and Proposals for Board Re-election

(IN BRIEF) Novo Nordisk A/S has announced the date for its Annual General Meeting, scheduled for Thursday, March 21, 2024, at 14:00 CET. The meeting will be held partially electronically, allowing shareholders to participate either in person at Bella Center … Read the full press release

Bristol Veterinary School Marks 75 Years of Leading Veterinary Medicine and Conservation

(IN BRIEF) In 2024, the University of Bristol’s Veterinary School commemorates 75 years of excellence in educating veterinary professionals and spearheading advancements in veterinary science. Established in 1949 following recommendations from the Loveday Committee, the school has evolved into a … Read the full press release

Fresenius Projects Robust Earnings Growth in 2024 Following Successful 2023

(IN BRIEF) Fresenius had a strong finish in 2023, with a robust fourth quarter performance. They project accelerated earnings growth in 2024 due to the momentum from their #FutureFresenius initiatives. Achieving their raised outlook for FY/23, the company saw continued … Read the full press release

Innovative TU/e Master’s Student Creates SUWEVE to Enhance Wheelchair Mobility

(IN BRIEF) Wouter Witteman, a master’s student in Embedded Systems at Eindhoven University of Technology (TU/e), is known for his innovative solutions. His latest venture, SUWEVE, aims to improve wheelchair mobility by allowing users to face backward while being pushed. … Read the full press release

Evonik to Introduce New Class of rPEG Lipids for Enhanced Immunogenicity in Drug Delivery

(IN BRIEF) Evonik has partnered with the University of Mainz to commercialize a new class of polyethylene glycols (PEGs) called randomized polyethylene glycols (rPEGs). These rPEGs will be integrated into Evonik’s specialized lipid platform for drug delivery in nucleic acid-based … Read the full press release

Philips Nominates New Members to Supervisory Board, Continues Focus on Healthcare Innovation

(IN BRIEF) Royal Philips, a prominent player in health technology, proposes the re-appointment of Chairman Feike Sijbesma and Peter Löscher to its Supervisory Board, along with the appointment of Benoît Ribadeau-Dumas as a new member. The nominations, to be voted … Read the full press release

Higher Education Leaders Call for Ministerial Taskforce to Address Decline in Healthcare Course Applications

(IN BRIEF) In response to the latest UCAS data indicating a decline in applications for medicine, nursing, and midwifery courses, leaders from various higher education groups are urging the government to establish a ministerial taskforce. This taskforce would facilitate collaboration … Read the full press release

AstraZeneca and Daiichi Sankyo’s Datopotamab Deruxtecan Moves Closer to Approval for Advanced NSCLC Treatment

(IN BRIEF) AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted by the FDA for the treatment of locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) in patients who have undergone prior … Read the full press release

AstraZeneca’s Tagrisso Shows Promise in Phase III LAURA Trial for EGFR-Mutated Lung Cancer

(IN BRIEF) AstraZeneca’s Tagrisso (osimertinib) demonstrates significant improvement in progression-free survival (PFS) for patients with unresectable, Stage III EGFR-mutated non-small cell lung cancer (NSCLC) after chemoradiotherapy (CRT) in the LAURA Phase III trial. The trial, led by Dr. Suresh Ramalingam, … Read the full press release

FDA Approves AstraZeneca’s Tagrisso Plus Chemotherapy for EGFR-Mutated Lung Cancer

(IN BRIEF) AstraZeneca’s Tagrisso receives FDA approval for treating adult patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC) following a Priority Review. The decision is based on FLAURA2 Phase III trial results demonstrating that Tagrisso plus … Read the full press release

Almirall Achieves Robust Growth in Dermatology Sector, Expands Pipeline with Licensing Agreement

(IN BRIEF) Almirall, a leading biopharmaceutical company specializing in medical dermatology, has reported its full-year 2023 financial results, showcasing a 4% year-on-year growth in net sales driven by the strong performance of its European Dermatology business. The company’s total EBITDA … Read the full press release

Almirall Secures Global Rights for Promising Dermatological Treatment, NN-8828, Targeting IL-21

(IN BRIEF) Almirall S.A., a leading pharmaceutical company specializing in medical dermatology, has finalized an exclusive license agreement with Novo Nordisk for the development and commercialization of NN-8828, an IL-21 blocking monoclonal antibody. This innovative treatment holds potential for various … Read the full press release

Dupixent® Receives Landmark Approval in Japan for Chronic Spontaneous Urticaria Treatment

(IN BRIEF) Japan’s Ministry of Health, Labor and Welfare (MHLW) has authorized the marketing and manufacturing of Dupixent® (dupilumab) for treating chronic spontaneous urticaria (CSU) in patients aged 12 years and older. This approval marks a significant milestone as Japan … Read the full press release

Newcastle University Lecturer Honored with National Award for Surgical Innovation

(IN BRIEF) Dr. Kenneth Rankin, an honorary senior lecturer at Newcastle University, was bestowed with the prestigious Researcher of the Year award at The Bone Idols 2024 ceremony for his outstanding contributions to surgical oncology. Recognized for his remarkable innovation … Read the full press release